Matches in Nanopublications for { ?s ?p "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1160279.RAZMXl4DZ_6nXTijukTWOLSh_QB5n5NrIl5_HRywJ125s130_assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1160279.RAZMXl4DZ_6nXTijukTWOLSh_QB5n5NrIl5_HRywJ125s130_provenance.
- NP784940.RAiEHKVoGUf3_yMLuptuao8MaYgkveDSaY-Rly4GgwZgQ130_assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784940.RAiEHKVoGUf3_yMLuptuao8MaYgkveDSaY-Rly4GgwZgQ130_provenance.
- NP1160277.RAnPDKwdh_yFX1-olwTXajW4QOzd0tiUHjWrPzFqGjRuE130_assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1160277.RAnPDKwdh_yFX1-olwTXajW4QOzd0tiUHjWrPzFqGjRuE130_provenance.
- NP785028.RA40_lPdGXcNuq1uvcOLr4faYWRPO4gkpOn3y96QlCcZY130_assertion description "[In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785028.RA40_lPdGXcNuq1uvcOLr4faYWRPO4gkpOn3y96QlCcZY130_provenance.